Cargando…
Priming with intranasal lactobacilli prevents Pseudomonas aeruginosa acute pneumonia in mice
BACKGROUND: Increasing resistance to antibiotics of Pseudomonas aeruginosa leads to therapeutic deadlock and alternative therapies are needed. We aimed to evaluate the effects of Lactobacillus clinical isolates in vivo, through intranasal administration on a murine model of Pseudomonas aeruginosa pn...
Autores principales: | Fangous, Marie-Sarah, Gosset, Philippe, Galakhoff, Nicolas, Gouriou, Stéphanie, Guilloux, Charles-Antoine, Payan, Christopher, Vallet, Sophie, Héry-Arnaud, Geneviève, Le Berre, Rozenn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237558/ https://www.ncbi.nlm.nih.gov/pubmed/34182930 http://dx.doi.org/10.1186/s12866-021-02254-7 |
Ejemplares similares
-
Porphyromonas, a potential predictive biomarker of Pseudomonas aeruginosa pulmonary infection in cystic fibrosis
por: Keravec, Marlène, et al.
Publicado: (2019) -
Proposal of a quantitative PCR-based protocol for an optimal Pseudomonas aeruginosa detection in patients with cystic fibrosis
por: Le Gall, Florence, et al.
Publicado: (2013) -
An observational study of anaerobic bacteria in cystic fibrosis lung using culture dependant and independent approaches
por: Lamoureux, Claudie, et al.
Publicado: (2021) -
Insights into the respiratory tract microbiota of patients with cystic fibrosis during early Pseudomonas aeruginosa colonization
por: Keravec, Marlène, et al.
Publicado: (2015) -
Prevotella melaninogenica, a Sentinel Species of Antibiotic Resistance in Cystic Fibrosis Respiratory Niche?
por: Lamoureux, Claudie, et al.
Publicado: (2021)